The buyer is trying to discount our recurring subscription revenue by pointing out that a significant portion of our customer base has a high churn rate within the first ninety days of sign-up, even though our overall customer lifetime value remains highly profitable. How do we defend our valuation multiple against this churn argument under the IVS 105 Income Approach?

Question

Tyler Smith · Accepted Answer

To protect your multiple, you must isolate your short-term trial churn from your long-term core customer base. Buyers use early churn to argue that your recurring revenue is actually unstable transactional revenue in disguise. You need to use the IVS 105 Income Approach to demonstrate the distinct economic value of your long-term subscribers.

Begin by running a cohort analysis that separates customers who leave within the first ninety days from those who stay past day ninety-one. Show that once a customer crosses the ninety-day threshold, their renewal rate is exceptionally high and their lifetime value is predictable. This proves that you have two distinct customer profiles: a low-cost trial group and a highly stable, high-margin core group.

Next, tie this operational reality to your EOS frameworks. Bring your leadership team together in a Level 10 Meeting™ to build an IDS® session around your customer acquisition cost. Prove that your marketing spend is highly targeted to offset early churn, meaning early attrition is already priced into your customer acquisition model.

In your negotiations, argue that your valuation should apply a premium multiple to the revenue generated by the seasoned cohort. Do not let the buyer apply a blanket discount to your entire top-line recurring revenue. By presenting a clean, cohort-based cash flow projection, you force the buyer to value your established subscription base under the Capitalization of Earnings method while isolating the early-stage trial revenue as a separate, lower-risk bucket.